Full Text View
Tabular View
No Study Results Posted
Related Studies
Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF)
This study has been completed.
Study NCT00520780   Information provided by Vifor Inc.
First Received: August 24, 2007   Last Updated: October 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Heart Failure
Iron Deficiency
Iron Deficiency Anemia
Anaemia
Additional conditions recognized in this trial
Anemia
Anemia, Iron-Deficiency
Deficiency Diseases
Heart Failure
Iron Metabolism Disorders
More general conditions related to this trial
Anemia, Hypochromic
Cardiovascular Diseases
Heart Diseases
Hematologic Diseases
Malnutrition
Metabolic Diseases
Nutrition Disorders
Interventions listed in this trial
Ferinject ® (Ferric carboxymaltose)
Normal saline (0.9%)
Additional drug interventions recognized in this trial
Iron
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Trace Elements
Sponsors listed in this trial
Vifor Inc.
Kendle International
ClinStar


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services